Zachary Roberts
Chief Tech/Sci/R&D Officer bij ALLOGENE THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Actieve functies van Zachary Roberts
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03-01-2023 | - |
Loopbaan van Zachary Roberts
Eerdere bekende functies van Zachary Roberts
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 01-03-2020 | 11-11-2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01-02-2018 | 01-05-2019 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01-01-2015 | 01-07-2015 |
Opleiding van Zachary Roberts
| University of Maryland | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Beurs
- Insiders
- Zachary Roberts
- Ervaring
